Abstract
Two populations of human blood lymphocytes--one forming rosettes with sheep erythrocytes, the other non-rosetting--are cytolytic in vitro for several long term cultured tumour-derived cell lines. A particular breast cancer-derived target cell (MDA-157) is only killed by the non-rosetting effector. Rosetting cells from normal donors infected or immunized with influenza virus augment cytolytic activity on MDA-157 targets by non-rosetting effector cells. Similar augmenting activity can be induced by incubating the rosetting population with sources of immune (gamma), but not leucocyte (alpha) interferon in vitro. This augmentation of cytolytic activity does not require compatibility at the major histocompatibility locus between the augmenting and effector populations.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beverley P. C., Callard R. E. Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody. Eur J Immunol. 1981 Apr;11(4):329–334. doi: 10.1002/eji.1830110412. [DOI] [PubMed] [Google Scholar]
- Brunda M. J., Herberman R. B., Holden H. T. Antibody-induced augmentation of murine natural killer cell activity. Int J Cancer. 1981 Feb 15;27(2):205–211. doi: 10.1002/ijc.2910270213. [DOI] [PubMed] [Google Scholar]
- Chun M., Fernandes G., Hoffmann M. K. Mechanism of NK cell activation: relationship between Qa5+ NK cells and lymphocytes. J Immunol. 1981 Jan;126(1):331–334. [PubMed] [Google Scholar]
- Einhorn S., Blomgren H., Strander H. Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon. Int J Cancer. 1980 Oct 15;26(4):419–428. doi: 10.1002/ijc.2910260406. [DOI] [PubMed] [Google Scholar]
- Herberman R. B., Djeu J., Kay H. D., Ortaldo J. R., Riccardi C., Bonnard G. D., Holden H. T., Fagnani R., Santoni A., Puccetti P. Natural killer cells: characteristics and regulation of activity. Immunol Rev. 1979;44:43–70. doi: 10.1111/j.1600-065x.1979.tb00267.x. [DOI] [PubMed] [Google Scholar]
- Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
- Kall M. A., Koren H. S. Heterogeneity of human natural killer cell populations. Cell Immunol. 1978 Sep 15;40(1):58–68. doi: 10.1016/0008-8749(78)90315-5. [DOI] [PubMed] [Google Scholar]
- Kendall R. A., Targan S. The dual effect of prostaglandin (PGE2) and ethanol on the natural killer cytolytic process: effector activation and NK-cell-target cell conjugate lytic inhibition. J Immunol. 1980 Dec;125(6):2770–2777. [PubMed] [Google Scholar]
- Klein G., Pearson G., Nadkarni J. S., Nadkarni J. J., Klein E., Henle G., Henle W., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med. 1968 Nov 1;128(5):1011–1020. doi: 10.1084/jem.128.5.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knight R. A., Fitzharris P. Separation of spontaneous-killing effector populations by target preference. Br J Cancer. 1980 Aug;42(2):243–251. doi: 10.1038/bjc.1980.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lipinski M., Virelizier J. L., Tursz T., Griscelli C. Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production. Eur J Immunol. 1980 Apr;10(4):246–249. doi: 10.1002/eji.1830100405. [DOI] [PubMed] [Google Scholar]
- Perussia B., Mangoni L., Engers H. D., Trinchieri G. Interferon production by human and murine lymphocytes in response to alloantigens. J Immunol. 1980 Oct;125(4):1589–1595. [PubMed] [Google Scholar]
- Potter M. R., Moore M. Natural cytotoxic reactivity of human lymphocyte subpopulations. Immunology. 1979 May;37(1):187–194. [PMC free article] [PubMed] [Google Scholar]
- Santoli D., Koprowski H. Mechanisms of activation of human natural killer cells against tumor and virus-infected cells. Immunol Rev. 1979;44:125–163. doi: 10.1111/j.1600-065x.1979.tb00269.x. [DOI] [PubMed] [Google Scholar]
- Santoli D., Trinchieri G., Moretta L., Zmijewski C. M., Koprowski H. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell. Clin Exp Immunol. 1978 Aug;33(2):309–318. [PMC free article] [PubMed] [Google Scholar]
- Saxena Q. B., Mezey E., Adler W. H. Regulation of natural killer activity in vivo. II. The effect of alcohol consumption on human peripheral blood natural killer activity. Int J Cancer. 1980 Oct 15;26(4):413–417. doi: 10.1002/ijc.2910260405. [DOI] [PubMed] [Google Scholar]
- Saxena R. K., Adler W. H. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line. J Immunol. 1979 Aug;123(2):846–851. [PubMed] [Google Scholar]
- Shellam G. R., Winterbourn V., Dawkins H. J. Augmentation of cell-mediated cytotoxicity to a rat lymphoma. III. In vitro stimulation of natural killer cells by a soluble factor. Int J Cancer. 1980 Mar 15;25(3):331–339. doi: 10.1002/ijc.2910250305. [DOI] [PubMed] [Google Scholar]
- Targan S., Dorey F. Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells. J Immunol. 1980 May;124(5):2157–2161. [PubMed] [Google Scholar]
- Trinchieri G., Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med. 1978 May 1;147(5):1314–1333. doi: 10.1084/jem.147.5.1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
